ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,652Medicare Part D Prescriptions Filled, Including Refills

Rank: 122 out of 1155

$345K Total Retail Price of All Prescriptions

Rank: 174 out of 1155

350 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 350 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

23% of this provider’s 350 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

4% of this provider’s 5,522 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
HYDROCODONE-ACETAMINOPHEN 524 311 S3 1 4
LEVOTHYROXINE SODIUM 326 259 2 2
SIMVASTATIN 265 245 3 3
OMEPRAZOLE 264 206 4 5
LISINOPRIL 185 163 5 1
AMLODIPINE BESYLATE 179 144 6 6
FUROSEMIDE 171 137 7 8
TRAZODONE HCL 123 90 8 22
ATORVASTATIN CALCIUM 118 89 9 12
OXYCODONE HCL 114 49 S2 10 23
WARFARIN SODIUM 114 107 10 11
PRAVASTATIN SODIUM 106 66 12 20
METFORMIN HCL 105 63 13 7
LOSARTAN POTASSIUM 103 95 14 18
FLUOXETINE HCL 100 58 15 30
POTASSIUM CHLORIDE 100 65 15 16
LOVASTATIN 99 96 17 13
ZOLPIDEM TARTRATE 98 96 18 21
GABAPENTIN 97 57 19 15
HYDROCHLOROTHIAZIDE 95 90 20 9
METOPROLOL TARTRATE 93 67 21 14
MORPHINE SULFATE ER 88 24 S2 22 36
ATENOLOL 82 75 23 10
CITALOPRAM HBR 81 57 24 19
LOSARTAN-HYDROCHLOROTHIAZIDE 81 61 24 65
ESTRADIOL 76 58 R 26 60
ADVAIR DISKUS 74 60 27 35
VENLAFAXINE HCL ER 73 33 28 68
METOPROLOL SUCCINATE 68 59 29 17
PREMARIN 68 53 R 29 110
ROPINIROLE HCL 63 62 31 94
AMITRIPTYLINE HCL 60 27 R 32 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 43 33 26
SERTRALINE HCL 59 27 33 24
CYCLOBENZAPRINE HCL 57 15 R 35 38
FENTANYL 56 38 S2 36 64
DIGOXIN 54 50 37 54
PANTOPRAZOLE SODIUM 51 37 38 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 26, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.